"Human gastric cancer" trang 1 - tải miễn phí từ tailieunhanh
Establishment and characterization of a metastasis model of human gastric cancer in nude mice

Establishment and characterization of a metastasis model of human gastric cancer in nude mice
10    52    1
Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL

Synergistic apoptosis of human gastric cancer cells by bortezomib and TRAIL
12    60    0
Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model

Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model
10    105    0
Plasma membrane proteomic analysis of human gastric cancer tissues: Revealing flotillin 1 as a marker for gastric cancer

Plasma membrane proteomic analysis of human gastric cancer tissues: Revealing flotillin 1 as a marker for gastric cancer
14    67    1
Fluctuating expression of miR-584 in primary and high-grade gastric cancer

Fluctuating expression of miR-584 in primary and high-grade gastric cancer
12    66    1
Expression of Reg IV and SOX9 and their correlation in human gastric cancer

Expression of Reg IV and SOX9 and their correlation in human gastric cancer
11    32    1
Tissue metabolic profiling of human gastric cancer assessed by 1 H NMR

Tissue metabolic profiling of human gastric cancer assessed by 1 H NMR
12    43    1
Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity

Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity
11    34    1
Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer

Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer
10    40    1
Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer

Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer
9    48    1
Young-onset gastric cancer and Epstein– Barr Virus (EBV) – a major player in the pathogenesis?

Young-onset gastric cancer and Epstein– Barr Virus (EBV) – a major player in the pathogenesis?
7    92    0
Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/β-catenin signaling

Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/β-catenin signaling
15    54    0
The FREGAT biobank: A clinico-biological database dedicated to esophageal and gastric cancers

The FREGAT biobank: A clinico-biological database dedicated to esophageal and gastric cancers
12    83    1
Positive prognostic value of HER2-HER3 coexpression and p-mTOR in gastric cancer patients

Positive prognostic value of HER2-HER3 coexpression and p-mTOR in gastric cancer patients
16    67    1
Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses

Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses
6    54    1
MiR-874 inhibits gastric cancer cell proliferation by targeting SPAG9

MiR-874 inhibits gastric cancer cell proliferation by targeting SPAG9
8    37    1
MicroRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer

MicroRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer
11    65    1
Expression of AE1/p16 promoted degradation of AE2 in gastric cancer cells

Expression of AE1/p16 promoted degradation of AE2 in gastric cancer cells
11    73    1
Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms

Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms
10    51    1
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): A multicenter, phase II trial

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): A multicenter, phase II trial
9    59    1